Skip to main content
. 2011 Dec 26;2011:548327. doi: 10.1155/2011/548327

Table 1.

Characteristics of patients in the study groups and predelivery thrombosis risk factors.

Thromboprophylactic Group A Group B
regimen Bemiparin 3500 IU/5 days Bemiparin 3500 IU/10 days
Number of cases (n) 311 335
Mean age ± SD 31.37 ± 5.24 31.06 ± 5.62
Age ≥35 years (n) (%) 89 (28.61%) 98 (29.25%)
Parity (n) (%)
 0 149 (47.9%) 174 (51.9%)
 1 90 (28.9%) 101 (30.1%)
 2 46 (14.8%) 41 (12.2%)
 3 13 (4.2%) 13 (3.9%)
 ≥4 13 (4.2%) 6 (1.8%)
BMI (n) (%)
 BMI > 30 142 (45.8%) 116 (34.62%)
 BMI > 35 36 (11.6%) 22 (6.56%)
Smoking (n) (%) 51 (16.5%) 40 (11.9%)
 >10 cigs./day 16 (16%) 9 (2.25%)
Drug consumption (n) (%) 1 (0.3%) 1 (0.3%)
Multiple pregnancy (n) (%) 13 (4.2%) 19 (5.6%)
Hypertension (n) (%)
 Chronic hypertension 6 (1.9%) 0
 PIH in previous pregnancy 4 (1.3%) 6 (1.8%)
 PIH in current pregnancy 34 (10.9%) 35 (10.4%)
Diabetes (n) (%) 15 (4.82%) 26 (1.8%)
 Type I 3 (1%) 2 (0.6%)
 Gestational diabetes 8 (2.6%) 18 (5.4%)
 Carbohydrate intolerance 4 (1.3%) 6 (1.8%)
Previous heart disease (n) (%) 0 1 (0.3%)
Immobility (n) (%) 0 1 (0.3%)

BMI: body mass index, PIH: pregnancy-induced hypertension.